title: Prevalence of maternal cytomegalovirus (CMV) antibody and detection of CMV DNA in amniotic fluid.
abstract: The prevalence of cytomegalovirus (CMV) IgG antibody was determined in 573 pregnant women in the first trimester. The overall prevalence of CMV IgG antibody was 77.5%. The rate of seropositivity was 67.7% in women < 25 yr, and increased with age to 85.7% in women 40 yr. These results imply that young women in Japan are at increased risk for primary CMV infection during pregnancy and that congenital CMV infection rates might increase in the future. We conducted a prospective study of 75 pregnant women who underwent amniocentesis for various indications to determine if CMV DNA could be detected in the amniotic fluid. None had symptoms associated with CMV infection, CMV IgM antibody, or seroconversion to CMV IgG antibody during pregnancy. CMV DNA was not detected in the amniotic fluid using a polymerase chain reaction assay. The 65 fetuses, including 3 sets of twins, were followed through birth. CMV DNA was not detected in urine samples obtained within the first 2 weeks of life. In conclusion, CMV DNA was not detected in the amniotic fluid of women who did not have CMV infection. These results, however, suggest that the negative predictive value of prenatal amniotic fluid analysis is high and that the presence of CMV DNA in the amniotic fluid has clinical significance for the diagnosis of congenital CMV infection if detected in pregnant women.
authors.affiliation: Department of Pediatrics, Japanese Red Cross Nagoya First Hospital, Aichi.
authors.forename: N
authors.initials: N
authors.lastname: Nishimura
authors.forename: H
authors.initials: H
authors.lastname: Kimura
authors.forename: Y
authors.initials: Y
authors.lastname: Yabuta
authors.forename: N
authors.initials: N
authors.lastname: Tanaka
authors.forename: Y
authors.initials: Y
authors.lastname: Ito
authors.forename: K
authors.initials: K
authors.lastname: Ishikawa
authors.forename: C
authors.initials: C
authors.lastname: Suzuki
authors.forename: T
authors.initials: T
authors.lastname: Morishima
mesh_terms: D000328:Adult; D000653:Amniotic Fluid / Q000821:virology*; D000914:Antibodies, Viral / Q000032:analysis*; D003587:Cytomegalovirus / Q000235:genetics / Q000276:immunology*; D003586:Cytomegalovirus Infections / Q000097:blood / Q000453:epidemiology / Q000276:immunology*; D004279:DNA, Viral / Q000032:analysis; D005260:Female; D005333:Fetus / Q000821:virology; D005500:Follow-Up Studies; D006801:Humans; D007231:Infant, Newborn; D008875:Middle Aged; D016133:Polymerase Chain Reaction / Q000379:methods; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000097:blood / Q000453:epidemiology / Q000276:immunology* / Q000821:virology; D015995:Prevalence; D011446:Prospective Studies; D012680:Sensitivity and Specificity
chemical_list: D000914:Antibodies, Viral; D004279:DNA, Viral